CIURLEO, ROSELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.402
EU - Europa 1.019
AS - Asia 422
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 2.846
Nazione #
US - Stati Uniti d'America 1.394
SE - Svezia 332
IE - Irlanda 327
CN - Cina 222
SG - Singapore 129
UA - Ucraina 98
DE - Germania 80
IT - Italia 69
VN - Vietnam 52
FI - Finlandia 47
GB - Regno Unito 26
IN - India 15
AT - Austria 11
BE - Belgio 8
CA - Canada 7
NL - Olanda 7
RU - Federazione Russa 6
FR - Francia 3
HK - Hong Kong 3
CZ - Repubblica Ceca 2
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
EU - Europa 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
PT - Portogallo 1
RO - Romania 1
Totale 2.846
Città #
Dublin 327
Chandler 315
Nyköping 222
Jacksonville 193
Singapore 105
Ashburn 104
Dearborn 87
Beijing 78
Princeton 56
Dong Ket 52
Medford 49
Cambridge 46
New York 44
Boardman 43
Des Moines 43
Jinan 23
Ann Arbor 18
Nanjing 18
Hebei 17
Wilmington 12
Woodbridge 12
Bremen 11
Messina 11
Los Angeles 9
Taiyuan 9
Vienna 9
Brussels 8
Hyderabad 8
Taizhou 8
Lancaster 7
Washington 7
Montréal 6
Shenyang 6
Nanchang 5
Tianjin 5
Catania 4
Changsha 4
Fuzhou 4
Haikou 4
Hefei 4
San Mateo 4
Seattle 4
West Jordan 4
Zhengzhou 4
Chicago 3
Falls Church 3
Guangzhou 3
Hangzhou 3
Helsinki 3
Jiaxing 3
Mcallen 3
Milan 3
Munich 3
Pietra Ligure 3
Turin 3
Auburn Hills 2
Campi Bisenzio 2
Houston 2
Kunming 2
London 2
Monmouth Junction 2
Ningbo 2
Nuremberg 2
Pavia 2
Pune 2
Santa Clara 2
Shanghai 2
Wuhan 2
Xian 2
Albuquerque 1
Amsterdam 1
Berlin 1
Brno 1
Brooklyn 1
Canelli 1
Canton 1
Cedar Knolls 1
Chengdu 1
Clearwater 1
Edinburgh 1
Giarre 1
Hanover 1
Hong Kong 1
Lausanne 1
Lecce 1
Lisbon 1
Mansfield 1
Meppel 1
Nanning 1
New Delhi 1
Newark 1
Norwalk 1
Perugia 1
Porto Potenza Picena 1
Quzhou 1
Redwood City 1
Rende 1
Rome 1
San Francisco 1
San Giovanni La Punta 1
Totale 2.101
Nome #
(1)H-MR Spectroscopy in Traumatic Brain Injury. 211
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 78
5-arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors 76
1H Magnetic Resonance Spectroscopy of the brain: methods for absolute quantification of metabolites 73
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 71
Diffusion - weighted imaging and fluid-attenuated inversion recovery sequence in sporadic Creutzfeldt-Jakob disease. One - case report. 70
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 69
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 69
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 67
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 67
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 65
Functional connectivity in vegetative state patients 65
Structure-based optimization of benzoic acids active as protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase inhibitors 64
Cortical reorganization in multiple sclerosis after intrathecal baclofen therapy. 62
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 61
Neurophysiological approach in comatose patients 59
Automatic Algorithm for Segmentation of Atherosclerotic Carotid Plaque 59
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatases inhibitors 58
Functional neuroimaging in differential diagnosis and outcome assessment of patients with disorders of consciousness 58
ROLE OF MAGNETIC RESONANCE SPECTROSCOPIC IN THE METABOLIC CHANGES IN DE NOVO PARKINSON’S DISEASE AFTER DOPAMINERGIC THERAPY 56
Functional evaluation of awareness in vegetative and minimally conscious state 56
Reality orientation therapy (ROT) in Alzheimer’s disease. 55
Nuovi inibitori competitivi non fosforilati delle fosfotirosina protein fosfatasi. 54
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 52
“2,4-Thiazolidinedione derivatives as potential agents for the treatment of type 2 diabetes and its chronic complications” 50
Nuovi 5-ariliden-2,4-tiazolidindioni non carbossilici inibitori dell'aldoso reduttasi 49
Nuovi 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 47
The clinical use of quality of life scales in the neurodegenerative diseases 45
ROLE OF RESVERATROL AND ITS ANALOGUES IN THE TREATMENT OF NEURODEGENERATIVE DISEASES: FOCUS ON RECENT DISCOVERIES, 45
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 43
Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives 43
The role of sativex in robotic rehabilitation in individuals with multiple sclerosis rationale, study design, and methodology 42
RUOLO DELLA RISONANZA MAGNETICA SPETTROSCOPICA NELLO STUDIO DELLE ALTERAZIONI METABOLICHE NELLA MALATTIA DI PARKINSON IN SEGUITO A TERAPIA DOPAMINERGICA 41
Evaluation of olfactory dysfunction in neurodegenerative diseases. 41
Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia 41
Titolo: Ruolo della risonanza magnetica spettroscopica nello studio delle alterazioni metaboliche nella malattia di Parkinson in seguito a terapia dopaminergica 40
Neurorehabilitation as a multidisciplinary approach: amyotrophic lateral sclerosis 39
Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries 39
Evaluation of olfactory dysfunction in neurodegenerative diseases 39
null 37
Effects of diffusion signal modeling and segmentation approaches on subthalamic nucleus parcellation 34
Post-traumatic olfactory loss: Psychophysical, electrophysiological and neuroradiological findings in three single case studies 34
Propranolol for familial cerebral cavernous malformation (Treat_CCM): Study protocol for a randomized controlled pilot trial 32
White matter substrates of functional connectivity dynamics in the human brain 31
Sintesi e valutazione in vitro di 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori di protein tirosina fosfatasi 31
Role of statins in the treatment of multiple sclerosis 31
In vivo probabilistic atlas of white matter tracts of the human subthalamic area combining track density imaging and optimized diffusion tractography 31
Olfactory event-related potentials in a functionally anosmic patient with arrested hydrocephalus 30
Transcriptomic data analysis reveals a down-expression of galectin-8 in schizophrenia hippocampus 30
Ventral intermediate nucleus structural connectivity-derived segmentation: anatomical reliability and variability 30
Neurogenic ejaculatory disorders: focus on current and future treatments. 29
Magnetic Resonance Spectroscopy: An In Vivo Molecular Imaging Biomarker for Parkinson’s Disease? 29
Persistent anosmia in a traumatic brain injury patient: role of orbitofrontal cortex. 26
The role of brain oscillations in post-stroke motor recovery: An overview 25
Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study 25
Striatal topographical organization: Bridging the gap between molecules, connectivity and behavior 24
In Vivo Super-Resolution Track-Density Imaging for Thalamic Nuclei Identification 23
Pharmacotherapy for disorders of consciousness: are 'awakening' drugs really a possibility? 18
Role of diffusion tensor imaging in the diagnosis and management of post-traumatic anosmia 7
Totale 2.876
Categoria #
all - tutte 12.826
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.826


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020299 0 0 0 0 0 67 87 52 5 21 65 2
2020/2021281 34 0 41 14 16 38 0 18 1 32 21 66
2021/2022334 2 24 7 8 31 1 55 6 8 15 48 129
2022/20231.122 95 114 44 97 92 124 27 56 425 8 28 12
2023/2024312 21 45 22 35 30 96 1 20 2 14 6 20
2024/2025173 7 15 38 67 46 0 0 0 0 0 0 0
Totale 2.876